Invention Grant
US09585902B2 Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone
有权
用于口服施用唑来膦酸或相关化合物治疗佩吉特氏骨病的组合物
- Patent Title: Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone
- Patent Title (中): 用于口服施用唑来膦酸或相关化合物治疗佩吉特氏骨病的组合物
-
Application No.: US15043141Application Date: 2016-02-12
-
Publication No.: US09585902B2Publication Date: 2017-03-07
- Inventor: Herriot Tabuteau
- Applicant: Antecip Bioventures II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Brent A. Johnson; Louis C. Cullman
- Main IPC: A61K31/663
- IPC: A61K31/663 ; A61K31/675 ; A61K9/20 ; A61K9/00 ; A61K9/28 ; A61K47/12 ; A61K45/06
Abstract:
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
Public/Granted literature
Information query
